About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 185 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 185 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 185 trials

CompletedBiologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyThe purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in patients with homogeneous emphysema.NCT00630227·Birmingham, Alabama and 7 others RecruitingA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseThis Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe…NCT07082738·Birmingham, Alabama and 366 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a history of or increased…NCT01313676·Andalusia, Alabama and 1610 others

CompletedStudy to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Primary Objective: Primary population (former smokers cohort): \- Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe…NCT04751487·Phoenix, Arizona and 237 others

WithdrawnUtility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPDListening to breath sounds with the stethoscope/auscultation is used by pulmonary physicians in conjunction with pulmonary function, signs and symptoms, oxygen saturation and…NCT05661435·Philadelphia, Pennsylvania and 1 other

CompletedEfficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)The purpose of this Phase III study is to evaluate the long-term safety and tolerability of two fixed-dose combinations of inhaled aclidinium bromide/formoterol fumarate…NCT01572792·Anniston, Alabama and 207 others

CompletedVideo-based Teach-to-goal Intervention on Inhaler Technique on Jordanian Adults With Asthma and COPDThis study was an interventional educational study that was intended to find out the effect of a video based inhaler technique education on improving inhaler technique mastery…NCT05664347·Amman

CompletedTiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)The objective of this study is to assess the efficacy and safety of 12 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC (delivered by the Respimat…NCT01964352·Wheat Ridge, Colorado and 76 others

CompletedEffects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)The investigators are looking at the effect of humidified nasal high-flow with oxygen (HNHF-O2) on air exchange during exacerbations of COPD.NCT03214458·Philadelphia, Pennsylvania

RecruitingSPIROMICS Study of Early COPD Progression (SOURCE)This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals.NCT05033990·Birmingham, Alabama and 13 others

CompletedA 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to evaluate the dose-response of different doses of CHF 5259 pMDI on lung function and other clinical outcomes, to identify the optimal dose(s) in…NCT03084796·Birmingham, Alabama and 111 others

Completed26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)Stage 1 of the study is designed to provide data about the risk-benefit of 4 dose regimens of indacaterol (75, 150, 300 \& 600 µg o.d.) in order to select two doses to carry…NCT00463567·Anniston, Alabama and 343 others

CompletedPennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsThe overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for…NCT00774176·Lancaster, Pennsylvania and 2 others

CompletedExtension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)This is a multi-center, randomized, double-blind, parallel group, chronic dosing, active-controlled, 28-week safety extension study of the two pivotal 24-week safety and efficacy…NCT01970878·Andalusia, Alabama and 124 others

RecruitingSupporting Evidence-based Responses to Emotional Needs in EmphysemaThe goal of this clinical trial is to understand how a Coping Skills Training program can reduce depression and anxiety in people with chronic obstructive pulmonary disease…NCT06600126·Detroit, Michigan and 1 other

CompletedRETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeThe study hypothesis is that symptomatic current and former smokers with spirometric values within the normal range (post-bronchodilator FEV1/FVC≥0.70 and post-BD FVC ≥ 70%…NCT02867761·Birmingham, Alabama and 15 others

CompletedA Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD PatientsThis is a Phase 2a, proof-of-concept, multicenter, randomized, double-blind, double dummy, 3-treatment, parallel study, with low and high YPL 001 doses (low dose and high dose…NCT02272634·Birmingham, Alabama and 3 others

CompletedEffects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalizationBackground: COPD exacerbations add considerably to patients' burden because they: (1) cause frequent hospital admissions and relapses or readmissions, (2) contribute directly to…NCT01973998·Philadelphia, Pennsylvania

TerminatedTelemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory FailureThe Hypercapnia Telemedicine Outreach Program (E-TOUCH Study) aims to utilize telemedicine technology, as well as emergency medical services (EMS) home visits to address the…NCT03353064·Philadelphia, Pennsylvania

CompletedEfficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsPhase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated…NCT04053634·Surprise, Arizona and 342 others

PreviousPage 5 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia